LifeStance Health Gr Q1 2024 GAAP EPS $(0.06) Beats $(0.08) Estimate, Sales $300.437M Beat $298.991M Estimate
LifeStance Health Gr Q1 2024 GAAP EPS $(0.06) Beats $(0.08) Estimate, Sales $300.437M Beat $298.991M Estimate
LifeStance Health Gr 2024年第一季度GAAP每股收益美元（0.06）超过预期（0.08），销售额3.00437亿美元超过预期的2.989.91亿美元
LifeStance Health Gr (NASDAQ:LFST) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 33.33 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $300.437 million which beat the analyst consensus estimate of $298.991 million by 0.48 percent. This is a 18.94 percent increase over sales of $252.589 million the same period last year.
LifeStance Health Gr（纳斯达克股票代码：LFST）公布的季度亏损为每股0.06美元，比分析师普遍预期的0.08美元（0.08美元）高出25％。与去年同期每股亏损0.09美元（0.09）相比，增长了33.33％。该公司公布的季度销售额为3.004.37亿美元，比分析师普遍预期的2.989.91亿美元高出0.48％。这比去年同期的2.52589亿美元的销售额增长了18.94％。